Taking care of our friends and neighbors: DeVita’s the death of cancer and the challenge of letting go

Tomasz M. Beer; Vinay Prasad

doi:10.1001/jamaoncol.2016.3076

Taking care of our friends and neighbors: DeVita’s the death of cancer and the challenge of letting go

Tomasz M. Beer, Vinay Prasad

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	16-17
Number of pages	2
Journal	JAMA Oncology
Volume	3
Issue number	1
DOIs	https://doi.org/10.1001/jamaoncol.2016.3076
State	Published - Jan 1 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2016.3076

Cite this

@article{9d4225e42c3b4b30bf5cd70541adce45,

title = "Taking care of our friends and neighbors: DeVita{\textquoteright}s the death of cancer and the challenge of letting go",

author = "Beer, {Tomasz M.} and Vinay Prasad",

note = "Funding Information: receiving research funding from Astellas, Bristol-Myers Squibb, Dendreon, Janssen Research & Development, Medivation, OncoGenex, Sotio, and Theraclone Sciences; receiving consulting fees from Astellas, AstraZeneca, Bayer, Churchill Pharmaceuticals, Dendreon, Janssen Biotech, Janssen Oncology, Janssen Research & Development, and Roche; and holding stock in Salarius Pharmaceuticals. No other disclosures were reported.",

year = "2017",

month = jan,

day = "1",

doi = "10.1001/jamaoncol.2016.3076",

language = "English (US)",

volume = "3",

pages = "16--17",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Taking care of our friends and neighbors

T2 - DeVita’s the death of cancer and the challenge of letting go

AU - Beer, Tomasz M.

AU - Prasad, Vinay

N1 - Funding Information: receiving research funding from Astellas, Bristol-Myers Squibb, Dendreon, Janssen Research & Development, Medivation, OncoGenex, Sotio, and Theraclone Sciences; receiving consulting fees from Astellas, AstraZeneca, Bayer, Churchill Pharmaceuticals, Dendreon, Janssen Biotech, Janssen Oncology, Janssen Research & Development, and Roche; and holding stock in Salarius Pharmaceuticals. No other disclosures were reported.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85013070500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013070500&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2016.3076

DO - 10.1001/jamaoncol.2016.3076

M3 - Short survey

C2 - 27631115

AN - SCOPUS:85013070500

SN - 2374-2437

VL - 3

SP - 16

EP - 17

JO - JAMA Oncology

JF - JAMA Oncology

IS - 1

ER -

Taking care of our friends and neighbors: DeVita’s the death of cancer and the challenge of letting go

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this